NEW YORK (TheStreet) -- CHANGE IN RATINGS
AMC Networks (AMCX) rated new Overweight at JP Morgan. $43 price target. Pullback has created an attractive buying opportunity in the growing company.
Amazon.com (AMZN) rated new Outperform at Morgan Keegan. $210 price target. Company can continue to gain market share in North America.
Acme Packet (APKT) rated new Neutral at JP Morgan. $29 price target. Inflection point in growth may still be several quarters away.Bill Barrett (BBG) downgraded to hold at TheStreet Ratings. Biglari Holdings (BH) downgraded to hold at TheStreet Ratings. Broadcom (BRCM) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call, as earnings should rebound in 2012. Boston Scientific (BSX) downgraded at Goldman to Sell, Goldman Sachs said. Consensus estimates appear too high. BorgWarner (BWA) downgraded at UBS from Buy to Neutral, UBS said. $68 price target. Europe headwinds remain despite german OEM exposure. Deckers (DECK) downgraded at Sterne Agee from Buy to Underperform, Sterne Agee said. Estimates also cut, following disappointing channel checks for UGG. $72 price target. First Solar (FSLR) downgraded at Baird from Outperform to Neutral, Robert Baird said. $35 price target. Company slashed it guidance and the business is in a transition period. Forest Oil (FST) rated new Hold at Keybanc. Company still has to show that it can generate growth in newer shale areas.
Gulfport Energy (GPOR) rated new Outperform at Credit Suisse. $41 price target. Utica shale should continue to drive growth. Hospira (HSP) rated new Sell at UBS. $25 price target. Recovery from manufacturing issues could be slow. ITC (ITC) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. Company can deliver above-average growth in the coming quarters. $79 price target. Kior (KIOR) upgraded at Baird from Underperform to Neutral, Robert Baird said. Valuation call, based on a $10 price target. Laboratory Corp. (LH) downgraded at Goldman to Sell, Goldman Sachs said. Industry is facing flat volumes and rising costs. Lam Research (LRCX) upgraded at Needham from Hold to Buy, Needham said. $46 price target. NVLS purchase will improve scale and customer leverage. PerkinElmer (PKI) upgraded at Goldman to Buy, Goldman Sachs said. Sentiment appears to have bottomed out for the group.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV